Literature DB >> 25459918

Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease.

LiYan Gao1, Ying Liu2, XiaoHong Li2, QuanHao Bai3, Ping Liu4.   

Abstract

OBJECTIVE: We investigated possible abnormalities in the retinal nerve fiber layer (RNFL) and macula lutea of patients diagnosed with Alzheimer's disease (AD) and mild cognitive impairment (MCI) and tested for any correlation with the severity of dementia.
METHODS: A total of 72 subjects, comprising 25 AD patients, 26 MCI patients and 21 healthy individuals (controls) were enrolled in this study. The thickness of the RNFL and volume of the macula lutea was determined using optical coherence tomography (OCT).
RESULTS: When compared with controls, we found statistically significant thinning of the RNFL in AD patients at all clock-hour positions except 12:00, and nasal quadrant, 2:00, 3:00 and 4:00. After adjusting several risk factors, the average thickness of the RNFL was reduced in MCI patients compared to AD patients, with specific reductions at inferior quadrant, 5:00 and 6:00. Compared to controls, MCI patients showed a significant decrease in RNFL thickness only in the temporal quadrant, 8:00, 9:00 and 10:00. We found significant reduction in the volume of the macula lutea both in AD and MCI patients. Finally, we could not establish any correlation between patient Mini-Mental State Examination (MMSE) scores (an estimation of the severity of cognitive impairment) and any OCT parameter.
CONCLUSION: Retinal degeneration in AD and MCI patients results in decreased thickness of the RNFL, and reduced macular volume in AD and MCI patients. However, there seems to be no correlation between these changes and the severity of dementia.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Mild cognitive impairment; Optical coherence tomography; Retinal nerve fiber layer

Mesh:

Year:  2014        PMID: 25459918     DOI: 10.1016/j.archger.2014.10.011

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  59 in total

1.  Peripapillary and macular choroidal thickness before and after phenylephrine instillation.

Authors:  Alfonso Casado; Alicia López-de-Eguileta; Jorge Gaitán; Soraya Fonseca; Miguel A Gordo-Vega
Journal:  Eye (Lond)       Date:  2019-06-04       Impact factor: 3.775

2.  Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia.

Authors:  Sukanto Sarkar; A R Rajalakshmi; S Avudaiappan; S Eswaran
Journal:  Int Ophthalmol       Date:  2021-04-15       Impact factor: 2.031

3.  Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography.

Authors:  Fang Ko; Zaynah A Muthy; John Gallacher; Cathie Sudlow; Geraint Rees; Qi Yang; Pearse A Keane; Axel Petzold; Peng T Khaw; Charles Reisman; Nicholas G Strouthidis; Paul J Foster; Praveen J Patel
Journal:  JAMA Neurol       Date:  2018-10-01       Impact factor: 18.302

4.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

5.  Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.

Authors:  Lauren M Wright; Thor D Stein; Gyungah Jun; Jaeyoon Chung; Kate McConnell; Marissa Fiorello; Nicole Siegel; Steven Ness; Weiming Xia; Kelley L Turner; Manju L Subramanian
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?

Authors:  Jeffrey Lambe; Olwen C Murphy; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2018-03-21       Impact factor: 3.598

8.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

Review 9.  Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.

Authors:  Thein Than Htike; Sachin Mishra; Sundramurthy Kumar; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2018-07-14       Impact factor: 5.590

Review 10.  Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.

Authors:  J P Cunha; N Moura-Coelho; R P Proença; A Dias-Santos; J Ferreira; C Louro; A Castanheira-Dinis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.